Not so fast, unfortunately we don't have access to RXNB books, as to their losses, especially the losses accrued through their massive product FDA re-call, or even their supposed $27M annual revenues. All I found online is this site that indicates revenues of $500k.
For the record, there are very few Pharma companies that generate revenues of $27M within three years. Lastly, it begs the question, if Bill and Sam were pulling in $27M, why seek outside financing for the Grow Op to begin with? Why give up 25% equity, if they seemingly had the capital?
Market Data 
Markets 
AI
